Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: September 5, 2026 at 12:22 AM UTC
| NCT Number | NCT05907980 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 209 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Chugai Pharmaceutical |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of September 5, 2026: Clinical trial NCT05907980 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 5 locations across the United States. The study is sponsored by Chugai Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05907980 is actively recruiting participants as of September 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05907980 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.